Literature DB >> 2129900

The generation and fate of thymocytes.

K Shortman1, M Egerton, G J Spangrude, R Scollay.   

Abstract

In the adult thymus the majority of thymocytes are at a non-proliferating end stage, during which 3% of all CD4+CD8+ cortical thymocytes are selected on the basis of appropriate T-cell antigen-receptor (TcR) specificity to become CD4-CD8+ or CD4+CD8- mature thymocytes. The selected mature cells gradually emigrate to the periphery. The 97% unselected, or positively rejected, CD4+CD8+ thymocytes die in the thymus. This 3-day end stage is, however, the product of around 2 weeks of proliferation by less mature thymocytes, which gives about a 10(5)-fold expansion from the hundred prothymocytes estimated to seed the thymus each day. Rearrangement and expression of TcR genes and a sequence of changes in surface antigens occurs during this prolonged period. Two sequential waves of expansion and differentiation appear to be involved. The first, about 1 week long, involves the less than 0.1% of thymocytes which still resemble the prothymocyte; this leads via a non-dividing interval to the second 1-week stage involving the 3% of CD4-CD8- thymocytes and then the CD4+CD8+ blasts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2129900

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  64 in total

1.  SATB1 cleavage by caspase 6 disrupts PDZ domain-mediated dimerization, causing detachment from chromatin early in T-cell apoptosis.

Authors:  S Galande; L A Dickinson; I S Mian; M Sikorska; T Kohwi-Shigematsu
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation.

Authors:  Onder Alpdogan; Stephanie J Muriglan; Jeffrey M Eng; Lucy M Willis; Andrew S Greenberg; Barry J Kappel; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 3.  Determinants of public T cell responses.

Authors:  Hanjie Li; Congting Ye; Guoli Ji; Jiahuai Han
Journal:  Cell Res       Date:  2012-01-03       Impact factor: 25.617

Review 4.  Role of gonadal hormones in programming developmental changes in thymopoietic efficiency and sexual diergism in thymopoiesis.

Authors:  Gordana Leposavic; Milica Perisic; Ivan Pilipovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

5.  Identifying specificity groups in the T cell receptor repertoire.

Authors:  Jacob Glanville; Huang Huang; Allison Nau; Olivia Hatton; Lisa E Wagar; Florian Rubelt; Xuhuai Ji; Arnold Han; Sheri M Krams; Christina Pettus; Nikhil Haas; Cecilia S Lindestam Arlehamn; Alessandro Sette; Scott D Boyd; Thomas J Scriba; Olivia M Martinez; Mark M Davis
Journal:  Nature       Date:  2017-06-21       Impact factor: 49.962

6.  Thymic and extrathymic contributions to T helper cell function in murine neonates.

Authors:  B Adkins; P Guevara; S Rose
Journal:  Haematol Rep       Date:  2006-09

7.  The effects of thymic selection on the range of T cell cross-reactivity.

Authors:  Dennis L Chao; Miles P Davenport; Stephanie Forrest; Alan S Perelson
Journal:  Eur J Immunol       Date:  2005-12       Impact factor: 5.532

8.  Dynamic control of β1 integrin adhesion by the plexinD1-sema3E axis.

Authors:  Young I Choi; Jonathan S Duke-Cohan; Wei Chen; Baoyu Liu; Jérémie Rossy; Thibault Tabarin; Lining Ju; Jingang Gui; Katharina Gaus; Cheng Zhu; Ellis L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-16       Impact factor: 11.205

Review 9.  Insights into thymic involution in tumor-bearing mice.

Authors:  Roberto Carrio; Diana M Lopez
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

10.  The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.

Authors:  Andrew N Macintyre; Valerie A Gerriets; Amanda G Nichols; Ryan D Michalek; Michael C Rudolph; Divino Deoliveira; Steven M Anderson; E Dale Abel; Benny J Chen; Laura P Hale; Jeffrey C Rathmell
Journal:  Cell Metab       Date:  2014-06-12       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.